Cargando…

Symptoms of COVID-19 Outpatients in the United States

BACKGROUND: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pathogen causing the current worldwide coronavirus disease 2019 (COVID-19) pandemic. Due to insufficient diagnostic testing in the United States, there is a need for clinical decision-making algorithms to guide testi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pullen, Matthew F, Skipper, Caleb P, Hullsiek, Kathy H, Bangdiwala, Ananta S, Pastick, Katelyn A, Okafor, Elizabeth C, Lofgren, Sarah M, Rajasingham, Radha, Engen, Nicole W, Galdys, Alison, Williams, Darlisha A, Abassi, Mahsa, Boulware, David R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337847/ https://www.ncbi.nlm.nih.gov/pubmed/33117855 http://dx.doi.org/10.1093/ofid/ofaa271

Ejemplares similares

Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials
por: Lofgren, Sarah M, et al.
Publicado: (2021)

Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
por: Lofgren, Sarah M, et al.
Publicado: (2020)

Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic
por: Pullen, Matthew F, et al.
Publicado: (2020)

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2020)

Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial
por: Lother, Sylvain A., et al.
Publicado: (2020)

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
por: Boulware, David R., et al.
Publicado: (2020)

Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
por: Rajasingham, Radha, et al.
Publicado: (2020)

Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation
por: Rhein, Joshua, et al.
Publicado: (2018)

Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes
por: Pastick, Katelyn A, et al.
Publicado: (2019)

Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
por: Skipper, Caleb P., et al.
Publicado: (2020)

1716. Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2019)

A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19—A Call for Clinical Trials
por: Pastick, Katelyn A, et al.
Publicado: (2020)

Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
por: Kagimu, Enock, et al.
Publicado: (2022)

Evaluation of the effectiveness of a South African laboratory cryptococcal antigen screening programme using a retrospective cohort and a cluster-randomised trial design
por: DeSanto, Daniel J, et al.
Publicado: (2022)

Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
por: Pastick, Katelyn A, et al.
Publicado: (2020)

Baseline Cytomegalovirus Viremia at Cryptococcal Meningitis Diagnosis Is Associated With Long-term Increased Incident TB Disease and Mortality in a Prospective Cohort of Ugandan Adults With HIV
por: Ellis, Jayne, et al.
Publicado: (2023)

The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017
por: Ellis, Jayne, et al.
Publicado: (2019)

Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis
por: Rolfes, Melissa A., et al.
Publicado: (2015)

Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006–2016
por: Flynn, Andrew G., et al.
Publicado: (2017)

2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis
por: Diehl, John W, et al.
Publicado: (2018)

Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults
por: Skipper, Caleb, et al.
Publicado: (2019)

Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective Cohort
por: Tugume, Lillian, et al.
Publicado: (2022)

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality
por: Skipper, Caleb P, et al.
Publicado: (2022)

Tuberculous meningitis diagnosis and outcomes during the Xpert MTB/Rif era: a 6.5-year cohort study in Uganda
por: Cresswell, Fiona V., et al.
Publicado: (2018)

Standardized Urine-Based Tuberculosis (TB) Screening With TB-Lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan Adults With Advanced Human Immunodeficiency Virus Disease and Suspected Meningitis
por: Cresswell, Fiona V, et al.
Publicado: (2020)

Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection
por: Mpoza, Edward, et al.
Publicado: (2018)

Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
por: Rajasingham, Radha, et al.
Publicado: (2014)

Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal Meningitis
por: Okafor, Elizabeth C., et al.
Publicado: (2020)

The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons
por: Rajasingham, Radha, et al.
Publicado: (2017)

Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic Review
por: Pastick, Katelyn A, et al.
Publicado: (2022)

869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial
por: Atukunda, Mucunguzi, et al.
Publicado: (2022)

Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding
por: Boulware, David R., et al.
Publicado: (2015)

Technical procedures and REDCap tools for internet-based clinical trials
por: Bangdiwala, Ananta S., et al.
Publicado: (2022)

The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis
por: Rolfes, Melissa A., et al.
Publicado: (2014)

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda
por: Lofgren, Sarah M., et al.
Publicado: (2018)

Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial
por: Scriven, James E., et al.
Publicado: (2015)

Differences in Reasons for Late Presentation to HIV Care in Uganda Among Men and Women
por: Lofgren, Sarah M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5f0osd4mrvnpmak67730h6lvqu